The latest trading session saw Goldman Sachs (GS) ending at $599.21, denoting a -0.77% adjustment from its last day's close. This move lagged the S&P 500's daily gain of 0.01%. Elsewhere, the Dow saw ...

(the "Company” or "89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and ...

A court denied a motion to block the shareholder vote on the Redfin-Rocket deal, but senators are voicing concerns over the proposed merger.

The housing market remains constrained in 2025. Goldman said mortgage rates will stay elevated, raising its year-end target ...

A stockholder had lodged litigation attempting to postpone the Redfin shareholder vote slated to take place June 4 based on a ...

Goldman Sachs has added these three stocks to its Conviction List. They all have at least 20% upside potential to the analyst ...

Investing.com -- Goldman Sachs upgraded Yum Brands to “Buy” from “Neutral,” saying the company is better placed than its ...

Goldman Sachs (GS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...

Simetrik, a leading AI reconciliation platform that enables enterprises to automate complex reconciliation processes, standardize financial data, and ensure compliance across millions of transactions ...

CoreWeave's stock surge appears disconnected from sustainable business expansion. Click here to see why CRWV stock is a Hold.

Investors largely shrugged off the latest blow to global trade from Donald Trump's White House on Wednesday as brokers upgraded expectations for stock markets this year.

Upstream Bio is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus ...